Back to top

Mizuho Securities Reaffirms Their Buy Rating on Tenet Healthcare (THC)

In a report released today, Ann Hynes from Mizuho Securities maintained a Buy rating on Tenet Healthcare, with a price target of $250.00. Hynes cov...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tenet Healthcare Corporation (THC)